Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis Psychedelics

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by Leafs4Lifeon Mar 31, 2017 6:49pm

114 Views

Post# 26061151

RE:RE:RE:RE:RE:Any updates on the financing?

IR actually can't give you information regarding the PP unless it is also made public. That would be material information and if you traded on that info it that would be an insider trade. So I wouldn't expect Phil to tell you anything until there is official word from LDS or Canaccord.

If the date was the 23rd to return the paperwork to Canaccord, it would probably be 2 weeks after that. We have been one week so far.

young_spanky wrote: Cheers Stranius - I appreciate that insight and makes sense. I just wish we could get that information from the company itself - i've not had any replies from IR or Skanderberg for over 6 weeks.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal